Versant Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.7K | Sell |
728
-43
| -6% | -$928 | ﹤0.01% | 1658 |
|
|
2025
Q1 | $12.8K | Buy |
771
+235
| +44% | +$3.9K | ﹤0.01% | 1591 |
|
|
2024
Q4 | $9.84K | Buy |
+536
| New | +$9.84K | ﹤0.01% | 1408 |
|
|
2023
Q4 | – | Sell |
-24
| Closed | -$500 | – | 1913 |
|
|
2023
Q3 | $500 | Hold |
24
| – | – | ﹤0.01% | 1693 |
|
|
2023
Q2 | $575 | Buy |
+24
| New | +$575 | ﹤0.01% | 1797 |
|
|
2023
Q1 | – | Sell |
-49
| Closed | -$780 | – | 1767 |
|
|
2022
Q4 | $780 | Hold |
49
| – | – | ﹤0.01% | 1357 |
|
|
2022
Q3 | $1K | Buy |
+49
| New | +$1K | ﹤0.01% | 1169 |
|
|
2021
Q4 | – | Sell |
-22
| Closed | – | – | 1414 |
|
|
2021
Q3 | $0 | Sell |
22
-114
| -84% | – | ﹤0.01% | 1427 |
|
|
2021
Q2 | $3K | Buy |
+136
| New | +$3K | ﹤0.01% | 1013 |
|
|
2021
Q1 | – | Sell |
-31
| Closed | -$1K | – | 1501 |
|
|
2020
Q4 | $1K | Sell |
31
-6
| -16% | -$194 | ﹤0.01% | 1177 |
|
|
2020
Q3 | $1K | Hold |
37
| – | – | ﹤0.01% | 1136 |
|
|
2020
Q2 | $1K | Hold |
37
| – | – | ﹤0.01% | 1131 |
|
|
2020
Q1 | $1K | Buy |
+37
| New | +$1K | ﹤0.01% | 1087 |
|